Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Dougherty

Showing results (171-180 of 212) with videos related to

Pageof 22
Sort By:
Journal of Gerontological Nursing|October 16, 2003
Bladder management in adult care homes. Review of a program in North CarolinaJean E Kincade, Alice R Boyington, Deborah Lekan-Rutledge, et al.
Journal of Aging and Health|April 7, 1997
Race differences in the health of elders who live aloneR T Coward, C W Peek, J C Henretta, et al.
International Urogynecology Journal and Pelvic Floor Dysfunction|April 20, 1999
Dietary caffeine, fluid intake and urinary incontinence in older rural womenB U Tomlinson, M C Dougherty, J F Pendergast, et al.
Urologic Nursing|September 20, 2007
Factors related to urinary incontinence in community-dwelling womenJean E Kincade, Molly C Dougherty, John R Carlson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 27, 2007
Efficacy of intravenous methoxy polyethylene glycol-epoetin beta administered every 2 weeks compared with epoetin administered 3 times weekly in patients treated by hemodialysis or peritoneal dialysis: a randomized trialMarian Klinger, Manual Arias, Vassilis Vargemezis, et al.
Current Medical Research and Opinion|May 24, 2007
Effect of a continuous erythropoietin receptor activator (C.E.R.A.) on stable haemoglobin in patients with CKD on dialysis: once monthly administrationFrancesco Locatelli, Giuseppe Villa, Angel L M de Francisco, et al.
ACS Omega|October 18, 2021
Exploration of the Role of the C-Terminal Domain of Human DNA Topoisomerase IIα in Catalytic ActivityAshley C Dougherty, Mariam G Hawaz, Kristine G Hoang, et al.
Research in Nursing & Health|April 5, 2002
Sociospatial knowledge networks: appraising community as placeAnne H Skelly, Thomas A Arcury, Wilbert M Gesler, et al.
International Journal of Clinical Practice|November 18, 2006
Continuous Erythropoietin Receptor Activator (C.E.R.A.) administered at extended administration intervals corrects anaemia in patients with chronic kidney disease on dialysis: a randomised, multicentre, multiple-dose, phase II studyA L M de Francisco, W Sulowicz, M Klinger, et al.
Neurourology and Urodynamics|July 5, 2007
Factors related to lower urinary tract symptoms among a sample of employed women in TaipeiYuan-Mei Liao, Molly C Dougherty, Paul P Biemer, et al.
Pageof 22

Showing results (171-180 of 212) with videos related to

Sort By:
Pageof 22
Journal of Gerontological Nursing|October 16, 2003
Bladder management in adult care homes. Review of a program in North CarolinaJean E Kincade, Alice R Boyington, Deborah Lekan-Rutledge, et al.
Journal of Aging and Health|April 7, 1997
Race differences in the health of elders who live aloneR T Coward, C W Peek, J C Henretta, et al.
International Urogynecology Journal and Pelvic Floor Dysfunction|April 20, 1999
Dietary caffeine, fluid intake and urinary incontinence in older rural womenB U Tomlinson, M C Dougherty, J F Pendergast, et al.
Urologic Nursing|September 20, 2007
Factors related to urinary incontinence in community-dwelling womenJean E Kincade, Molly C Dougherty, John R Carlson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 27, 2007
Efficacy of intravenous methoxy polyethylene glycol-epoetin beta administered every 2 weeks compared with epoetin administered 3 times weekly in patients treated by hemodialysis or peritoneal dialysis: a randomized trialMarian Klinger, Manual Arias, Vassilis Vargemezis, et al.
Current Medical Research and Opinion|May 24, 2007
Effect of a continuous erythropoietin receptor activator (C.E.R.A.) on stable haemoglobin in patients with CKD on dialysis: once monthly administrationFrancesco Locatelli, Giuseppe Villa, Angel L M de Francisco, et al.
ACS Omega|October 18, 2021
Exploration of the Role of the C-Terminal Domain of Human DNA Topoisomerase IIα in Catalytic ActivityAshley C Dougherty, Mariam G Hawaz, Kristine G Hoang, et al.
Research in Nursing & Health|April 5, 2002
Sociospatial knowledge networks: appraising community as placeAnne H Skelly, Thomas A Arcury, Wilbert M Gesler, et al.
International Journal of Clinical Practice|November 18, 2006
Continuous Erythropoietin Receptor Activator (C.E.R.A.) administered at extended administration intervals corrects anaemia in patients with chronic kidney disease on dialysis: a randomised, multicentre, multiple-dose, phase II studyA L M de Francisco, W Sulowicz, M Klinger, et al.
Neurourology and Urodynamics|July 5, 2007
Factors related to lower urinary tract symptoms among a sample of employed women in TaipeiYuan-Mei Liao, Molly C Dougherty, Paul P Biemer, et al.
Pageof 22